In yesterday’s Wall Street session, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares traded at $1.33, down -66.67% from the previous session.
As of this writing, 1 analysts cover Adamis Pharmaceuticals Corporation (NASDAQ:ADMP). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $105.00 and a low of $105.00, we find $105.00. Given the previous closing price of $3.99, this indicates a potential upside of 2531.58 percent. ADMP stock price is now -39.29% away from the 50-day moving average and -84.97% away from the 200-day moving average. The market capitalization of the company currently stands at $4.27M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
There are 1 analysts who have given it a hold rating, whereas 0 have given it a buy rating. Brokers who have rated the stock have averaged $105.00 as their price target over the next twelve months.
With the price target maintained at $1.50, Maxim Group recently Upgraded its rating from Hold to Buy for Adamis Pharmaceuticals Corporation (NASDAQ: ADMP).
A total of 7.81% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ADMP stock. A new stake in Adamis Pharmaceuticals Corporation shares was purchased by ARMISTICE CAPITAL, LLC during the first quarter worth $276,000. CITADEL ADVISORS LLC invested $6,000 in shares of ADMP during the first quarter.
During the past 12 months, Adamis Pharmaceuticals Corporation has had a low of $1.31 and a high of $27.80. The fifty day moving average price for ADMP is $2.1474 and a two-hundred day moving average price translates $8.8144 for the stock.
According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.06, missing analysts’ expectations of -$0.03 by -0.03. This compares to -$0.08 EPS in the same period last year. The company reported revenue of $1.45 million for the quarter, compared to $1.16 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 25.8 percent. For the current quarter, analysts expect ADMP to generate $1.51M in revenue.
